Menu
  • Join
  • Login
  • Contact
 

Search abstracts / presentations


Selenite antagonizes the anticancer activity of imatinib in human laryngeal cancer cells.

  • In: Poster Presentation
  • At: Stockholm (Sweden) (2017)
  • Type: Poster
  • Poster code: P-A-076-Tuesday
  • By: ABDEL-AZIZ, Amal Kamal (Faculty of Pharmacy, Ain Shams University, Department of Pharmacology and Toxicology, Cairo, Egypt)
  • Co-author(s): Amal Kamal Abdel-Aziz: Department of Pharmacology and Toxicology, Faculty of Pharmacy, Ain Shams University, Cairo, Egypt
    Samar Azab : Department of Pharmacology and Toxicology, Faculty of Pharmacy, Ain Shams University, Cairo, Egypt
    Abeer El-Sayed: Tissue culture and cytogenetics unit, Pathology Department, National Cancer Institute, Cairo University, Cairo, Egypt
    Ebtehal El-Demerdash : Department of Pharmacology and Toxicology, Faculty of Pharmacy, Ain Shams University, Cairo, Egypt
    Samia Shouman: Cancer Biology Department, National Cancer Institute, Cairo University, Cairo, Egypt
  • Abstract:

    Backgrounds

    Laryngeal cancer is the most common type of head and neck carcinomas. To date, limited anticancer agents are effective in treating laryngeal cancer whose survival rates are non-satisfactory. Although preferential overexpression of several tyrosine receptors has been demonstrated in heads and neck carcinoma specimens compared to benign

    ..

  • The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 28 September 2023

FIP Congresses